PyrotInib in combination with Capecitabine for trasTUzumab-REsistant, HER2-positive advanced breast cancer (PICTURE): a multicenter phase 2 trial

被引：0
|
作者：
Hu, Xichun
Cao, Jun
Teng, Yue'e
Li, Hui-Ping
Zhang, Lili
Ouyang, Quchang
Xie, Weimin
Pan, Yueyin
Song, Zhenchuan
Ling, Xiaoling
Wu, Xiaohong
Xu, Jingwei
Li, Li
Ren, Liping
Wang, Hong
Zhou, Dongxian
Luo, Jing
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P4-01-43
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-01-43
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Pyrotinib for Elderly Patients with Advanced HER2-Positive Breast Cancer
    Li, Yan
    Ma, Xiaoping
    Zhao, Zhenhui
    Li, Li
    Gao, Chunyan
    Liu, Dan
    Li, Bingyu
    Zhao, Bing
    BREAST CANCER-TARGETS AND THERAPY, 2022, 14 : 405 - 415
  • [22] Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical Trial
    Li, Qiao
    Guan, Xiuwen
    Chen, Shanshan
    Yi, Zongbi
    Lan, Bo
    Xing, Puyuan
    Fan, Ying
    Wang, Jiayu
    Luo, Yang
    Yuan, Peng
    Cai, Ruigang
    Zhang, Pin
    Li, Qing
    Zhong, Dafang
    Zhang, Yifan
    Zou, Jianjun
    Zhu, Xiaoyu
    Ma, Fei
    Xu, Binghe
    CLINICAL CANCER RESEARCH, 2019, 25 (17) : 5212 - 5220
  • [23] Dual-targeted therapy with pyrotinib and trastuzumab for HER2-positive advanced colorectal cancer: Preliminary results from a multicenter phase 2 trial.
    Yuan, Ying
    Fu, Xianhua
    Ying, Jieer
    Yang, Liu
    Fang, Weijia
    Han, Weidong
    Zhang, Suzhan
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [24] Pyrotinib and trastuzumab combination treatment synergistically overcomes HER2 dependency in HER2-positive breast cancer: insights from the PHILA trial
    Liu, Shuning
    Lan, Bo
    Wang, Yuanyi
    Yang, Tao
    Li, Lixi
    Ge, Hewei
    Zeng, Cheng
    Xu, Binghe
    Qian, Haili
    Ma, Fei
    EBIOMEDICINE, 2024, 109
  • [25] Trastuzumab-resistant HER2-positive metastatic breast cancer: Comparing results of lapatinib and capecitabine in brain and other metastatic sites.
    Cortes, E. J.
    Bomfim, M.
    Freitas, B. V.
    Muller, F.
    Silva, E. R.
    da Silva, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [26] Pyrotinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer : a multicenter, open-label, phase 2 trial
    Cao, F.
    Ma, Z.
    Hu, G.
    Zhu, X.
    Li, S.
    Chen, S.
    Chen, B.
    Li, Z.
    Wu, W.
    Ji, X.
    Shu, J.
    Tao, D.
    Hu, X.
    Zheng, M.
    Wang, O.
    Feng, Q.
    Hao, J.
    Li, X.
    BREAST, 2023, 68 : S16 - S16
  • [27] Signature-guided biomarker discovery and therapy for trastuzumab-resistant HER2-positive breast cancer
    Yin, J.
    Sand, A.
    Sun, C.
    Piacsek, M.
    Beres, A.
    Tjoe, J. A.
    CANCER RESEARCH, 2019, 79 (04)
  • [28] Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer models
    Buocikova, Verona
    Longhin, Eleonora Marta
    Pilalis, Eleftherios
    Mastrokalou, Chara
    Miklikova, Svetlana
    Cihova, Marina
    Poturnayova, Alexandra
    Mackova, Katarina
    Babelova, Andrea
    Trnkova, Lenka
    El Yamani, Naouale
    Zheng, Congying
    Rios-Mondragon, Ivan
    Labudova, Martina
    Csaderova, Lucia
    Kuracinova, Kristina Mikus
    Makovicky, Peter
    Kucerova, Lucia
    Matuskova, Miroslava
    Cimpan, Mihaela Roxana
    Dusinska, Maria
    Babal, Pavel
    Chatziioannou, Aristotelis
    Gabelova, Alena
    Runden-Pran, Elise
    Smolkova, Bozena
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 147
  • [29] Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
    Verma, Sunil
    Miles, David
    Gianni, Luca
    Krop, Ian E.
    Welslau, Manfred
    Baselga, Jose
    Pegram, Mark
    Oh, Do-Youn
    Dieras, Veronique
    Guardino, Ellie
    Fang, Liang
    Lu, Michael W.
    Olsen, Steven
    Blackwell, Kim
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (19): : 1783 - 1791
  • [30] Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2-positive breast cancer
    Kalinsky, Kevin
    Chi, Dow-Chung
    Lee, Shing Mirn
    Adelson, Kerin B.
    Crew, Katherine D.
    Chuang, Ellen
    Makower, Della
    Hershman, Dawn L.
    Califano, Andrea
    Silva, Jose
    Maurer, Matthew A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345